Bhavin Vyas

1.9k total citations
65 papers, 1.5k citations indexed

About

Bhavin Vyas is a scholar working on Pharmaceutical Science, Public Health, Environmental and Occupational Health and Molecular Biology. According to data from OpenAlex, Bhavin Vyas has authored 65 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Pharmaceutical Science, 11 papers in Public Health, Environmental and Occupational Health and 10 papers in Molecular Biology. Recurrent topics in Bhavin Vyas's work include Advanced Drug Delivery Systems (17 papers), Drug Solubulity and Delivery Systems (11 papers) and Advancements in Transdermal Drug Delivery (10 papers). Bhavin Vyas is often cited by papers focused on Advanced Drug Delivery Systems (17 papers), Drug Solubulity and Delivery Systems (11 papers) and Advancements in Transdermal Drug Delivery (10 papers). Bhavin Vyas collaborates with scholars based in India, United States and Australia. Bhavin Vyas's co-authors include Furqan A. Maulvi, Ketan M. Ranch, Ankita R. Desai, Dinesh O. Shah, Pranav Shah, Shailesh Shah, Rutvi J. Vaidya, Manish R. Shukla, Akshay R. Koli and Rahul Patil and has published in prestigious journals such as SHILAP Revista de lepidopterología, Journal of Controlled Release and Acta Biomaterialia.

In The Last Decade

Bhavin Vyas

61 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Bhavin Vyas India 21 656 531 339 242 179 65 1.5k
Xianggen Wu China 25 549 0.8× 446 0.8× 495 1.5× 251 1.0× 205 1.1× 79 1.7k
Veli‐Pekka Ranta Finland 23 455 0.7× 440 0.8× 650 1.9× 366 1.5× 522 2.9× 64 1.8k
Rajendra S. Kadam United States 18 295 0.4× 245 0.5× 389 1.1× 232 1.0× 343 1.9× 27 1.2k
Wessam H. Abd-Elsalam Egypt 16 541 0.8× 203 0.4× 176 0.5× 53 0.2× 69 0.4× 27 973
Ranendra Narayan Saha India 24 723 1.1× 149 0.3× 413 1.2× 119 0.5× 79 0.4× 75 1.9k
R. Leverge France 12 601 0.9× 385 0.7× 204 0.6× 124 0.5× 158 0.9× 26 1.0k
Mina Ibrahim Tadros Egypt 23 1.2k 1.8× 173 0.3× 298 0.9× 59 0.2× 42 0.2× 49 1.7k
Adriana Maltese Italy 12 537 0.8× 224 0.4× 226 0.7× 60 0.2× 91 0.5× 19 916
Elisabetta Muntoni Italy 27 837 1.3× 166 0.3× 852 2.5× 74 0.3× 62 0.3× 50 2.1k
Venkata Yellepeddi United States 20 250 0.4× 138 0.3× 488 1.4× 67 0.3× 52 0.3× 55 1.1k

Countries citing papers authored by Bhavin Vyas

Since Specialization
Citations

This map shows the geographic impact of Bhavin Vyas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bhavin Vyas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bhavin Vyas more than expected).

Fields of papers citing papers by Bhavin Vyas

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bhavin Vyas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bhavin Vyas. The network helps show where Bhavin Vyas may publish in the future.

Co-authorship network of co-authors of Bhavin Vyas

This figure shows the co-authorship network connecting the top 25 collaborators of Bhavin Vyas. A scholar is included among the top collaborators of Bhavin Vyas based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bhavin Vyas. Bhavin Vyas is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Patel, Mitali, Puja Patel, & Bhavin Vyas. (2025). Hyaluronic Acid Conjugated Liposomes for Targeted Delivery of Ibrutinib: In Vitro, Cell Line, and In Vivo Assessment. BioNanoScience. 15(2). 1 indexed citations
4.
Patel, Mitali, et al.. (2023). Inhalable dry powder containing lipid polymer hybrid nanoparticles of Nintedanib esylate: In vitro and in vivo evaluations. Journal of Drug Delivery Science and Technology. 86. 104716–104716. 10 indexed citations
5.
Shah, Pranav, et al.. (2023). Quality-by-Design-Based Development of Rivaroxaban-Loaded Liquisolid Compact Tablets with Improved Biopharmaceutical Attributes. AAPS PharmSciTech. 24(7). 176–176. 10 indexed citations
6.
Patel, Mitali, et al.. (2023). Core Shell Lipid-Polymer Hybrid Nanoparticles for Oral Bioavailability Enhancement of Ibrutinib via Lymphatic Uptake. AAPS PharmSciTech. 24(6). 142–142. 11 indexed citations
7.
Shah, Pranav, et al.. (2022). Amalgamation of solid dispersion and melt adsorption techniques for augmentation of oral bioavailability of novel anticoagulant rivaroxaban. Drug Delivery and Translational Research. 12(12). 3029–3046. 8 indexed citations
9.
Adeyemi, Sherif Babatunde, et al.. (2021). Effect of co-administration of metformin and extracts of Costus pictus D.Don leaves on alloxan-induced diabetes in rats. Journal of Traditional and Complementary Medicine. 12(3). 269–280. 18 indexed citations
10.
Khadela, Avinash, et al.. (2021). Impact of clinical pharmacist services on quality adjusted life years in head and neck cancer patients. International Journal of Clinical Pharmacy. 43(5). 1208–1217. 9 indexed citations
11.
Shah, Pranav, et al.. (2020). Formulation development of linagliptin solid lipid nanoparticles for oral bioavailability enhancement: role of P-gp inhibition. Drug Delivery and Translational Research. 11(3). 1166–1185. 61 indexed citations
12.
Desai, Ankita R., Furqan A. Maulvi, Manish R. Shukla, et al.. (2020). Multiple drug delivery from the drug-implants-laden silicone contact lens: Addressing the issue of burst drug release. Materials Science and Engineering C. 112. 110885–110885. 75 indexed citations
13.
Vyas, Bhavin, et al.. (2019). Repurposing of Iloperidone: Antihypertensive and ocular hypotensive activity in animals. European Journal of Pharmaceutical Sciences. 143. 105173–105173. 5 indexed citations
14.
Vyas, Bhavin, et al.. (2016). SIMULTANEOUS DETERMINATION OF NITRITE AND NITRATE BY ULTRA-PERFORMANCE LIQUID CHROMATOGRAPHY IN RAT PLASMA. International Journal of Pharmacy and Pharmaceutical Sciences. 8(6). 294–296. 2 indexed citations
15.
Vyas, Bhavin, et al.. (2013). Effect of Boerhaavia diffusa in experimental prostatic hyperplasia in rats. Indian Journal of Pharmacology. 45(3). 264–264. 22 indexed citations
16.
Shah, Payal D., et al.. (2012). Toxicity study of ethanolic extract of Acorus calamus rhizome. International Journal of Green Pharmacy. 6(1). 29. 20 indexed citations
17.
Vyas, Bhavin, et al.. (2011). Alteration of gastric mucus secretion in rats treated with Abelmoschusesculentus seed mucilage. Der pharmacia lettre. 3(5). 183–188. 7 indexed citations
18.
Vyas, Bhavin, et al.. (2011). Protective effect of aqueous extract of Oroxylum indicum Linn. (root bark) against DNBS-induced colitis in rats. Indian Journal of Pharmacology. 43(6). 656–656. 36 indexed citations
19.
Vyas, Bhavin, et al.. (2010). Evaluation of anti-inflammatory activities of n-butanol extract from Pergularia daemia in experimental animal models.. Journal of Pharmacy Research. 3(12). 3039–3044. 3 indexed citations
20.
Vyas, Bhavin, et al.. (2010). Assessment of the antidiabetic potential of Cassia grandis using an in vivo model. Journal of Advanced Pharmaceutical Technology amp Research. 1(3). 330–330. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026